DIABETES jab Ozempic and the weight-loss drug Wegovy have soared in popularity in recent months. But there has been concern that the class of drugs – called glucagon-like peptide-1 recep Read this story
DIABETES jab Ozempic and the weight-loss drug Wegovy have soared in popularity in recent months. But there has been concern that the class of drugs – called glucagon-like peptide-1 recep Read this story
More from The Scottish Sun | Section: Health:News Health Cancer Diet nutrition and weight loss Drugs Health warnings medicine NHS Health News Health